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Connexin26 gap junction mediates 
miRNA intercellular genetic 
communication in the cochlea 
and is required for inner ear 
development
Yan Zhu*, Liang Zong*, Ling Mei & Hong-Bo Zhao
Organ development requires well-established intercellular communication to coordinate cell 
proliferations and differentiations. MicroRNAs (miRNAs) are small, non-coding RNAs that can broadly 
regulate gene expression and play a critical role in the organ development. In this study, we found 
that miRNAs could pass through gap junctions between native cochlear supporting cells to play a role 
in the cochlear development. Connexin26 (Cx26) and Cx30 are predominant isoforms and co-express 
in the cochlea. Cx26 deficiency but not Cx30 deficiency can cause cochlear developmental disorders. 
We found that associated with Cx26 deletion induced the cochlear developmental disorders, deletion 
of Cx26 but not Cx30 disrupted miRNA intercellular transfer in the cochlea, although inner ear gap 
junctions still retained permeability after deletion of Cx26. Moreover, we found that deletion of Cx26 
but not Cx30 reduced miR-96 expression in the cochlea during postnatal development. The reduction 
is associated with the cochlear tunnel developmental disorder in Cx26 knockout (KO) mice. These 
data reveal that Cx26-mediated intercellular communication is required for cochlear development 
and that deficiency of Cx26 can impair miRNA-mediated intercellular genetic communication in the 
cochlea, which may lead to cochlear developmental disorders and eventually congenital deafness as 
previously reported.
Tissue homeostasis and organ development rely on the well-orchestrated integration of intercellular com-
munication and gene regulation to synchronize and coordinate cell proliferation and differentiation1. Gap 
junctions are intercellular channels and represent the only selective intercellular conduit that possesses 
a large pore size (1.0–1.5 nm), allowing direct exchange of ions and small molecules between cells2. It 
has been reported that small regulatory RNAs, such as siRNAs and miRNAs, can also pass through gap 
junctions3–10, which provides a novel mechanism for intercellular genetic communication11. In particular, 
miRNAs are single-stranded RNAs consisting of ~21 nucleotides and can broadly modulate gene expres-
sion by affecting the translation of mRNAs to proteins and mRNA target decay12–15. To date, approx-
imately 300 conserved miRNA families and thousands of additional poorly conserved miRNAs have 
been identified in mammals. Approximately two thirds of all human protein-coding genes are conserved 
targets of miRNAs13,14. Thus, miRNAs provide a widespread mechanism for post-transcriptional control 
of gene expression and are important for the organ development.
Gap junctions have a crucial role in hearing. Connexin26 (Cx26, GJB2) mutations cause most cases of 
hereditary genetic deafness, responsible for > 50% of nonsyndromic hearing loss16,17. Recently, we found 
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that Cx26 deficiency can cause cochlear developmental disorders leading to congenital deafness18,19. 
However, the underling mechanism for developmental disorders remains unclear. In this study, we found 
that miRNAs can pass through gap junctions in the cochlea. Cx26 and Cx30 are predominant connexin 
isoforms in the cochlea20,21. Associated with Cx26 deficiency induced cochlear developmental disorders, 
Cx26 deficiency but not Cx30 deletion disrupted miRNA-mediated intercellular genetic communication 
in the cochlea.
Results
Gap junction and Cx26 and Cx30 expression in the cochlea. The organ of Corti has hair cells 
and supporting cells (Fig. 1a). The auditory sensory hair cells have no gap junctional coupling and con-
nexin expression (Fig. 1f and also see ref. 20, 21). Gap junctions and connexin expression only existed in 
supporting cells (Fig. 1c–f). The organ of Corti contains four types of supporting cells, i.e., Deiters cells 
(DC), pillar cells (PC), Hensen cells (HC), and Claudius cells (CC) (see Supplementary Fig. S1). All of 
them had Cx26 and Cx30 expression and were well-coupled (Fig. 1 and also see ref. 20,21).
Intercellular transfer of miRNAs between cochlear supporting cells. MicroRNAs can pass 
through gap junctions between cochlear supporting cells (Figs 2, 5a,b and Supplementary Fig. S2). When 
fluorescence-tagged miRNA (miR-F) was injected into a cochlear supporting cell, the miR-F fluorescence 
could be detected in neighboring cells in the cochlear sensory epithelium (Fig. 5a,b) or in isolated cell 
preparation (Fig. 2). Out of a total of 20 injections (3 injections in DCs, 2 injections in PCs, 7 injections 
in HCs, and 8 injections in CCs), intercellular diffusion was observed in 18 injections. In two cases of 
no intercellular diffusion, the input capacitance (Cin) was at single cell level and demonstrated that the 
gap junctions between the recording cells were already uncoupled.
Blockage of miRNA intercellular transfer by gap junctional blockers. The intercellular transfer 
of miRNAs between cochlear supporting cells could be blocked by gap junctional blockers. Fig. 3 shows 
that application of 50 μ M 18α -glycyrrhetinic acid (18-AGA) or 0.1 mM carbenoxolone (CBX) gap junc-
tional blockers blocked miR-F diffusion between cells. The injected miR-F nucleotides were restricted 
within the injected cell and did not diffuse into the adjacently-contacted cells. Gap junction blocker 
blocked not only miR-F diffusion but also dye ethidium bromide (EB) diffusion between cells (Fig. 3d).
Cochlear development disorders and disruption of miRNA intercellular transfer in Cx26 KO 
mice. As previously reported18,22, deletion of Cx26 could induce cochlear developmental disorders 
(Fig. 4). The tectorial membrane was attached to the inner sulcus cells and the cochlear tunnel was filled 
(Fig. 4e). Deletion of Cx26 also disrupted intercellular transfer of miRNAs in the cochlea (Fig. 5). The 
injected miR-F was restricted to the injected cell (Fig. 5c–f). In all 12 injections, no intercellular diffu-
sion of miR-F was visible. However, deletion of Cx26 did not completely disrupt inner ear gap junctions, 
which still retained permeability to dye EB (Fig. 5g,h). Input capacitance (Cin) recording also indicated 
Figure 1. Cochlear structure and co-expression of Cx26 and Cx30 in the cochlea. (a) Schematic drawing 
of the cochlear structure in the cross-section. PC: Pillar cell, DC: Deiters cell, HC: Hensen cell, CC: Claudius 
cell. (b–e) Immunofluorescent staining for Cx26 (green) and Cx30 (red) in the cochlea. A white arrow in 
panel (b) indicates the cochlear tunnel. TM: tectorial membrane. (f) A high-magnitude image in the organ 
of Corti. Outer hair cells were visualized by prestin labeling (red). Scale bars: 25 μ m in (b–e), 10 μ m in (f).
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that cochlear supporting cells in Cx26 KO mice still retained good gap junctional coupling. Cin in the 
recording Hensen cells in Fig. 5e,f and Claudius cells in Fig. 5g,h was ~75 pF and 19.3 pF, respectively, 
showing that they were well-coupled.
Normal cochlear development and miRNA intercellular transfer in Cx30 KO mice. Cx30 is 
co-expressed with Cx26 in the cochlea (Fig. 1, and also see ref. 20, 21). However, deletion of co-expressed 
Cx30 displayed normal cochlear development (Fig. 6a–b). Intercellular transfer of miR-F also appeared 
normal in Cx30 KO mice and intercellular diffusion of miR-F among supporting cells was visible 
(Fig. 6c–f).
Reduction of miRNA expression in Cx26 KO mice during cochlear postnatal develop-
ment. MicroRNA-96 is critical for cochlear development23. In mouse postnatal development, the coch-
lear tunnel starts to open at postnatal day 5 (P5) and fully opens at P10 (Fig. 7a). We found that prior 
to the cochlear tunnel opening, the expression of miR-96 in the cochlea was increased at P3 (Fig. 7b). 
Then, the expression decreased and reached a steady state at P10. However, the expression of miR-96 in 
Cx26 KO mice was not increased at P3 and remained at lower level during the postnatal period (Fig. 7b). 
On the other hand, the expression of miR-96 in the cochlea in Cx30 KO mice, which displayed normal 
cochlear development (Fig. 6a), was similar to WT mice, increasing at P3 and then reducing afterward 
Figure 2. Time-lapse recording of intercellular transfer of miR-F between cochlear supporting cells.  
(a–d) Diffusion of miR-F between Hensen cells. The miR-F nucleotides were injected into a Hensen cell 
by the patch pipette. Arrows indicate a neighboring cell with miR-F labeling. (e–h) Intercellular diffusion 
of miR-F and EB between Claudius cells. The patch pipette was filled with a mixture of miR-F and EB. EB 
labeling is mainly visible at cell nuclei because of EB binding to DNAs. Scale bars: 10 μ m.
Figure 3. Blockage of miRNA and EB diffusion between the cochlear supporting cells by gap junctional 
blockers. (a,b) Blockage of intercellular diffusion of miR-F between Hensen cells by application of 50 μ M 
18-AGA. (c,d) Intercellular difussion of miR-F and EB between Claudius cells was blocked by application of 
0.1 mM CBX. All images were captured after injection for 30 min. Scale bars: 10 μ m.
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during the postnatal development (Fig.  7b). There was no significant difference in miR-96 expression 
between Cx30 KO mice and WT mice (P = 0.43, one-way ANOVA).
Discussion
In this study, we found that miRNAs could pass through gap junctions between native cochlear support-
ing cells (Figs 2, 5a,b and Supplementary Fig. S2). Deletion of Cx26 disrupted cochlear development and 
miRNA intercellular transfer in the cochlea (Figs.  4 and 5). However, the inner ear gap junctions still 
remainted permeability to cationic dye EB after Cx26 deletion (Fig 5g,h). Deletion of Cx26 also reduced 
Figure 4. Cx26 deletion in the cochlear sensory epithelium and developmental disorders in Cx26 KO 
mice. (a,b) Immunofluorescent staining for Cx26 in the cochlear sensory epithelium of WT mice. (c,d) 
Immunofluorescent staining for Cx26 (green) and Cx30 (red) of the cochlear sensory epithelium in the Cx26 
KO mice. No Cx26 labeling is visible but Cx30 labeling remains. (e,f) Cochlear developmental disorders in 
Cx26 KO mice. The tectorial-membrane attaches to the inner sulcus cells (indicated by arrow heads) and 
the cochlear tunnel is filled (indicated by a black arrow). Outer hair cells (OHCs) are visualized by prestin 
labeling (red). Immunofluorescent staining for Cx26 (green) is negative. Scale bars: 100 μ m in (a–d), 25 μ m 
in (e,f).
Figure 5. Disruption of the intercellular transfer of miRNAs between cochlear supporting cells in Cx26 
KO mice. (a,b) Intercellular transfer of miR-F in the mouse cochlear sensory epithelium. The injection 
site (indicated by a red asterisk in panel (a)) locates at the Hensen cell region in the cochlear sensory 
epithelium. (c,d) Disruption of miR-F intercellular transfer in the cochlear sensory epithelium in Cx26 KO 
mice. A red asterisk in panel c indicates the injection site, where locates at the Hensen cell region. (e,f) 
Disruption of intercellular transfer of miRNA between cochlear supporting cells in Cx26 KO mice in the 
isolated cell preparation. The injected miR-F is limited in the injected Hensen cell. Cin is ~75 pF, indicating 
that these cells are well-coupled by gap junctions. (g,h) Disruption of intercellular diffusion of miR-F but 
not EB between cochlear supporting cells. The pipette was filled with a mixture of miR-F and EB. An arrow 
indicates that a neighboring Claudius cell only has red EB labeling but no miR-F labeling. Cin is 19.3 pF, 
indicating that two cells are coupled. All images were captured after injection for 30 min. Scale bars: 25 μ m 
in (a–d), 10 μ m in (e–h).
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miR-96 expression in the cochlea during postnatal development and the reduction is associated with 
over-development of the cochlear tunnel (Fig. 7). However, consistent with the normal cochlear devel-
opment in Cx30 KO mice, deletion of Cx30 did not affect intercellular transfer of miRNA and miR-96 
expression in the cochlea (Figs  6 and 7b). We previously reported that miRNAs can pass through gap 
junctional channels and regulate gene expression in neighboring cells to achieve intercellular genetic 
communication11. Our new data further demonstrate that this gap junction-mediated miRNA intercel-
lular communication may have an important role in the cochlear development.
Deletion of Cx26 can result in filling of the cochlear tunnel and attachment of the tectorial mem-
brane to inner sulcus cells leading to loss of the under-tectorial-membrane space (Figs  4e,7a, and 
Figure 6. Normal cochlear development and miRNA intercellular transfer in the cochlea in Cx30 KO 
mice. (a–b) Normal cochlear development in the Cx30 KO mice. A white arrow in panel (a) indicates the 
open cochlear tunnel. Panel (b) shows immunofluorescent staining for Cx30. No Cx30 labeling is visible. 
(c–d) Intercellular transfer of miR-F between cochlear supporting cells in Cx30 KO mice. Cin = 43 pF.  
(e–f) Intercellular transfer of miR-F and EB between a pair of Hensen cells in Cx30 KO mice. Cin = 35.5 pF. 
All images were captured after injection for 30 min. Scale bars: 25 μ m (a–b), 10 μ m in (c–f).
Figure 7. Cochlear tunnel development and expression of miR-96 in the cochlea during cochlear 
postnatal development. (a) Postnatal development of the organ of Corti in wild-type (WT) and Cx26 
KO mice. The cochlear tunnel occurs at postnatal day 5 (P5) in WT mice (indicated by white arrows) but 
is filled in the Cx26 KO mice (indicated by red arrows). Scale bars: 20 μ m. (b) Dynamic changes of miR-
96 expression in the Cx26 KO, Cx30 KO, and WT mouse cochlea during postnatal development. WT 
littermates were used as control. The expression levels were normalized to that at P1 for comparison of 
dynamic changes. **P < 0.001, one-way ANOVA with a Bonferroni correction.
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also see ref. 17–19,22). Currently, the underlying mechanism remains unclear. In this experiment, we 
found that prior to the cochlear tunnel opening, miR-96 expression had a rapid increase at P3 (Fig. 7). 
This peak was missed in Cx26 KO mice but not in Cx30 KO mice (Fig.  7b). We hypothesize that this 
up-regulation of miRNA expression may be associated with arresting of cochlear supporting cell differ-
entiation leading to formation of the cochlear tunnel. Deletion of Cx26 impaired intercellular transfer 
of miRNAs between cochlear supporting cells (Fig. 5), which may lead to over-proliferation and differ-
entiation of cochlear supporting cells inducing over-development of the cochlear tunnel and loss of the 
under-tectorial-membrane space. This concept is further supported by the fact that deletion of Cx26 
disrupted miRNA permeability but not EB permeability in the cochlea (Fig. 5). This implies that coch-
lear gap junctions in Cx26 KO mice still retain permeability to ions and other small molecules, since 
co-expressed Cx30 expression remains (Fig. 4d, and also see ref. 24). Thus, some of gap junctional func-
tions in the cochlea, such as K+-recycling, in Cx26 KO mice may still remain normal. These data also 
further support our previous reports that Cx26 deficiency impairs cochlear developmental disorders and 
active cochlear amplification rather than K+-recycling resulting in hearing loss17–19,24,25.
In the experiment, we found that deletion of Cx30 did not affect miRNA permeability in the coch-
lea (Fig.  6) and had no influence on miR-96 expression (Fig.  7b). This is consistent with our previous 
report that inner ear gap junctions have strong charge-selectivity and that Cx26 is mainly responsible 
for anionic permeability in the cochlea26. MicroRNAs are anionic at physiological pH. It has been found 
that Cx30 channels are impermeable to anionic molecules27,28 and miRNAs11. Thus, deletion of Cx30 
could have little effect on permeability to miRNAs in the cochlea (Fig. 6). These data also suggest that 
Cx26 may have a critical role not only in intercellular signaling in the cochlea26 but also in intercellular 
genetic communication and development in the cochlea. This may be a reason why Cx26 rather than 
Cx30 deletion can induce cochlear developmental disorders.
Cx30 deficiency can also induce hearing loss17,29–31. However, hearing loss mainly results from 
endocochlear potential (EP) reduction17,19,29 rather than from cochlear developmental disorders as shown 
in Cx26 deficiency.
MicroRNAs provide a widespread mechanism for post-transcriptional control of gene expression. 
Gene expression can be regulated by many factors at many stages, such as enhancer and promoter, 
transcription factors, and mRNA polyA polymerization. However, none of these regulatory factors is 
intercellular-exchangeable through gap junctions except small non-coding RNAs such as miRNA. Gap 
junctions extensively exist in almost all cell types and organs. Recently, it has been found that miRNAs 
can be exchanged between tumor cells in a gap junction-dependent manner7–9. Thus, gap junction medi-
ated intercellular genetic communication can play an important role in organ development and may also 
be important for tumor genesis or inhibition.
Methods
Cx26 KO and Cx30 KO mice and genotyping. Cx26 KO mice were generated by crossing Cx26loxP/loxP  
mice (European Mouse Mutant Archive, EM00245) with the Pax2-Cre mouse line (the Mutation Mouse 
Regional Center, Chapel Hill, NC)18. The Cx26 floxed allele was detected on tail genomic DNA by PCR 
amplification using the following primers: Cx26F: 5′-CTT TCC AAT GCT GGT GGAGTG-3′ and Cx26R: 
5′-ACA GAA ATG TGT TGG TGA TGG-3′18. Cx26loxP/loxP and wild-type (WT) mice generated 400 and 
300 bps bands, respectively. For the Pax2-Cre transgene, the following primers were used: CreF: 5′-GCC 
TGC ATT ACC GGT CGA TGC AAC GA- 3′ and CreR: 5′-GTG GCA GAT GGC GCG GCA ACA CCA 
TT- 3′. The band size was 700 bps. Cx30 KO mice19,29 were also purchased from EMMA (EM000323). 
Primer pairs for detecting Cx30 KO were Cx30 KO-1 (LACZ e Neo): 5′-GGT ACC TTC TAC TAA 
TTA GCT TGG -3′; Cx30 KO2 (LACZ e Neo): 5′-AGG TGG TAC CCA TTG TAG AGG AAG -3′; 
Cx30 KO-3 (LACZ e Neo) 5′-AGC GAG TAA CAA CCC GTC GGA TTC -3′. The bands of Cx30 KO 
and WT mice were 460 and 544 bps, respectively.
The experimental procedures were approved by the University of Kentucky′ s Animal Care & Use 
Committee and conducted according to the standards of the NIH Guidelines for the Care and Use of 
Laboratory Animals.
Cochlear cell isolation and intracellular injection. Adult mice (30–60 day old) were decapitated 
and the temporal bone was removed. As we previously reported32–35, the otic capsule was opened and the 
cochlea was isolated by micro-dissection in a standard extracellular solution (142 NaCl, 5.37 KCl, 1.47 
MgCl2, 2 CaCl2, 10 HEPES in mM, 300 mOsm, pH 7.2). The sensory epithelium was micro-dissected by a 
sharpened needle. The isolated sensory epithelium was dissociated by trypsin (1 mg/ml) for 3–5 min32–35. 
The dissociated cells were then transferred to a dish for recording. The cochlear supporting cells and hair 
cells can be unambiguously identified under microscope by their own morphological shapes (Fig. S1, and 
also see ref. 26,32,33). The dissociated supporting cells also retained good gap junctional coupling33–35.
To assess intercellular permeation of gap junctions to miRNAs, a fluorescence-tagged miRNA (miR-F), 
which is constructed by a 25 nt miRNA (5′-CCT CTT ACC TCA GTT ACA ATT TATA-3′) labeled with 
carboxyfluorescein on its 3′ end (Gene Tools, Inc. OR), was used. This miR-F was proven to not be 
hybridized or degraded and also had no fluorescent tag removal in the cytoplasm36,37.
For dye injection to assess intercellular diffusion, a group or pair of cochlear supporting cells 
was selected. Intracellular injection was performed by patch clamp recording under the whole-cell 
www.nature.com/scientificreports/
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configuration26. The patch pipette was 1.5–2 μ m in tip diameter and filled with the normal intracellular 
solution (KCl 140, EGTA 5, and HEPES 10 in mM, pH 7.2 and 300 mOsm) with 100 μ M miR-F. The 
holding voltage was set at − 40 mV. Gap junctional coupling between cells was continuously monitored 
by input capacitance (Cin), which was recorded online at 1–3 Hz and calculated from the transient charge 
elicited by small (− 10 mV) test pulses at the holding potential33,34. The diffusion was captured with a 
CCD camera under a fluorescence microscope (Nickon, TE300) as we previously reported26.
In some cases, cationic dye ethidium bromide (EB, 0.1 mM) was also used and mixed with miR-F for 
injection. EB can distinctly identify the transjunctional-diffused cells and clearly demonstrate transjunc-
tional transport, because it can bind to DNAs labeling cell nuclei showing bright fluorescence.
Immunofluorescent staining. The immunofluorescent staining was performed as previously 
reported21,38. The cochlear section or culture cells were fixed with 4% paraformaldehyde for 30 min and 
washed out with PBS. After 30 min of incubation in a blocking solution (10% goat serum and 1% BSA 
in PBS) with 0.1% Triton X-100, the cochlear section or culture cells were incubated with monoclonal 
mouse anti-Cx26 (1: 400, Cat#33–5800, Invitrogen) in the blocking solution at 4 oC overnight. For dou-
ble immunofluorescent staining for Cx26 and Cx30, polyclonal rabbit anti-Cx30 (1:400, Cat#71–2200, 
Invitrogen), or polyclonal goat anti-prestin (1:50, Cat# sc-22694, Santa Cruz Biotech Inc, CA) was used. 
After being washed with PBS, the section or cells were incubated with corresponding Alexa Fluor 488- 
or 568-conjugated goat anti-mouse IgG and Alexa Fluor 568-conjugated goat anti-rabbit IgG (1:500, 
Molecular Probes) in the blocking solution at room temperature (23 oC) for 1 hr. In some cases, following 
the 2nd antibody incubation, the section or cells were stained by 4′ , 6-diamidino-2-phenylindole (DAPI, 
0.1 mg/ml, D1306; Molecular Probes) for ~15–20 min to visualize cell nuclei. After completely washing 
out with PBS, the section or cells were mounted with a fluorescence mounting medium (H-1000, Vector 
Lab, CA) and observed under a fluorescence microscope (Nickon, T2000) or a confocal microscope 
(Leica TCS SP2). The fluorescent image was saved in the TIFF format and assembled in Photoshop 
(Adobe Systems, CA) for presentation.
miRNA extraction and quantitative PCR measurement. The cochlear sensory epithelia were 
freshly isolated as described above and miRNAs were extracted by mirVana miRNA Isolation Kit 
(AM1560, Ambion, USA) following manufacturer’s instructions. The purity and quantity of miRNA 
was determined by a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Inc., Rockland, 
DE). Then, miRNAs were converted to cDNA using TaqMan® MicroRNA Reverse Transcription Kit 
(#4366596, Applied Biosystems, CA, USA) with corresponding mouse-specific miRNA reverse tran-
scription templates according to manufacturer’s instructions and measured by use of MyiQ real-time 
PCR detection system (Bio-Rad Laboratories) with TaqMan® MicroRNA Assay (Applied Biosystems, 
CA, USA). An internal standard U6 snRNA (#001973, Applied Biosystems, CA) was used as an internal 
control. The relative quantity of miRNA expression was calculated from the standard curve39 and nor-
malized to the amount of the internal standard U6 snRNA.
Data analysis. Data were expressed as mean ± s.e.m. and plotted by SigmaPlot (SPSS Inc. Chicago, 
IL). The statistical analyses were performed by SPSS v18.0 (SPSS Inc. Chicago, IL) using one-way ANOVA 
with a Bonferroni correction.
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